Edward Pershing - CEO, Director at PROVECTUS BIOPHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Issuer Symbol
PVCT on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Edward Pershing since 10 Jan 2025

Holdings reported by Edward Pershing for PROVECTUS BIOPHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series D-1 Convertible Preferred Stock 2,503,379 16 Oct 2025 Direct Common Stock
8% Unsecured Convertible Promissory Note $1,465,000 11 Dec 2025 Direct Series D-1 Convertible Preferred Stock

Transactions reported by Edward Pershing for PROVECTUS BIOPHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.